Role of MT1 melatonin receptors in methamphetamine-induced locomotor sensitization in C57BL/6 mice
Rationale Melatonin modifies physiological and behavioral responses to psychostimulants, with the MT 1 and MT 2 melatonin receptors specifically implicated in facilitating methamphetamine (METH)-induced sensitization in melatonin-proficient mice. Objective The objective of the study is to assess dif...
Gespeichert in:
Veröffentlicht in: | Psychopharmacology 2014-01, Vol.231 (1), p.257-267 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Rationale
Melatonin modifies physiological and behavioral responses to psychostimulants, with the MT
1
and MT
2
melatonin receptors specifically implicated in facilitating methamphetamine (METH)-induced sensitization in melatonin-proficient mice.
Objective
The objective of the study is to assess differences in locomotor sensitization after a single dose of methamphetamine in low-melatonin-expressing C57BL/6 wild-type and MT
1
receptor knockout (MT
1
KO) mice, comparing with melatonin-expressing C3H/HeN mice.
Methods
Mice received a vehicle or methamphetamine (1.2 mg/kg, i.p.) pretreatment (day 1) during the light (ZT5-9) or dark (ZT 19–21) periods in novel test arenas. Locomotor sensitization was assessed by methamphetamine challenge after an eight-day abstinence (day 9). TH protein expression was evaluated by immunofluorescence and Western blot analysis.
Results
Methamphetamine pretreatment induced statistically significant locomotor sensitization upon challenge after eight-day abstinence in C3H and C57 wild-type mice during the light period. The magnitude of sensitization in C57 mice was diminished in the dark period and completely abrogated in MT
1
KO mice. No differences were observed in tyrosine hydroxylase immunoreactivity in the mesolimbic dopamine system. Additional exposures to the test arenas after methamphetamine pretreatment (nights 2–6) enhanced sensitization.
Conclusions
Deletion of the MT
1
melatonin receptor abolishes sensitization induced by a single METH pretreatment. The magnitude of sensitization is also altered by time of day and contextual cues. We conclude that the MT
1
melatonin receptor is emerging as a novel target of therapeutic intervention for drug abuse disorders. |
---|---|
ISSN: | 0033-3158 1432-2072 |
DOI: | 10.1007/s00213-013-3228-0 |